BNP Paribas Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.8M Sell
1,016,891
-8,828
-0.9% -$294K 0.08% 241
2025
Q1
$30.1M Buy
1,025,719
+83,530
+9% +$2.45M 0.08% 242
2024
Q4
$31M Buy
942,189
+35,145
+4% +$1.15M 0.08% 256
2024
Q3
$40.3M Sell
907,044
-4,131
-0.5% -$184K 0.1% 208
2024
Q2
$39.3M Sell
911,175
-197,438
-18% -$8.51M 0.1% 205
2024
Q1
$32.4M Buy
1,108,613
+62,153
+6% +$1.82M 0.09% 239
2023
Q4
$23.3M Buy
1,046,460
+44,057
+4% +$981K 0.06% 281
2023
Q3
$24.8M Buy
1,002,403
+74,144
+8% +$1.84M 0.08% 260
2023
Q2
$26.3M Sell
928,259
-98,328
-10% -$2.78M 0.08% 246
2023
Q1
$23.6M Buy
1,026,587
+10,708
+1% +$246K 0.08% 258
2022
Q4
$28.5M Buy
1,015,879
+90,449
+10% +$2.54M 0.1% 232
2022
Q3
$26.2M Buy
925,430
+30,472
+3% +$862K 0.1% 227
2022
Q2
$19.8M Sell
894,958
-62,972
-7% -$1.4M 0.08% 288
2022
Q1
$27.9M Buy
957,930
+97,587
+11% +$2.84M 0.1% 248
2021
Q4
$28.3M Buy
860,343
+59,929
+7% +$1.97M 0.09% 255
2021
Q3
$36.9M Sell
800,414
-4,446
-0.6% -$205K 0.14% 187
2021
Q2
$44.4M Buy
804,860
+12,708
+2% +$700K 0.16% 159
2021
Q1
$40.9M Buy
792,152
+76,074
+11% +$3.93M 0.17% 144
2020
Q4
$31M Buy
716,078
+305,856
+75% +$13.3M 0.14% 180
2020
Q3
$14.4M Buy
410,222
+60,514
+17% +$2.12M 0.08% 269
2020
Q2
$18.7M Sell
349,708
-69,890
-17% -$3.74M 0.13% 194
2020
Q1
$14.9M Sell
419,598
-41,904
-9% -$1.49M 0.13% 207
2019
Q4
$22M Buy
461,502
+105,712
+30% +$5.05M 0.15% 187
2019
Q3
$11.5M Buy
355,790
+40,663
+13% +$1.32M 0.09% 273
2019
Q2
$15.7M Buy
315,127
+32,782
+12% +$1.64M 0.13% 217
2019
Q1
$19M Buy
282,345
+91,696
+48% +$6.18M 0.16% 180
2018
Q4
$8.64M Sell
190,649
-59,774
-24% -$2.71M 0.08% 308
2018
Q3
$19.3M Buy
250,423
+48,631
+24% +$3.75M 0.15% 196
2018
Q2
$17M Buy
201,792
+34,101
+20% +$2.87M 0.14% 194
2018
Q1
$13.7M Sell
167,691
-84,469
-33% -$6.91M 0.12% 247
2017
Q4
$14.4M Sell
252,160
-3,926
-2% -$224K 0.12% 238
2017
Q3
$17.1M Buy
256,086
+50,445
+25% +$3.37M 0.14% 189
2017
Q2
$10.6M Buy
205,641
+45,671
+29% +$2.35M 0.09% 292
2017
Q1
$9.34M Buy
159,970
+28,025
+21% +$1.64M 0.09% 323
2016
Q4
$5.51M Buy
131,945
+30,238
+30% +$1.26M 0.05% 451
2016
Q3
$5.37M Buy
+101,707
New +$5.37M 0.05% 496